Mountain Crest Acquisition V's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Mountain Crest Acquisition V's ROA in the second quarter of 2026?
Mountain Crest Acquisition Corp V recorded a cumulative net loss of $0 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -12.15%.

However, within the Healthcare sector 384 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3689, from total ROA ranking in the first quarter of 2026 at 4405.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	296.45 %	-18.6 %	-24.48 %	-79.06 %	-75.07 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	0	0	0	-1	-1
Return On Assets (TTM)	-12.15 %	-33.05 %	-37.27 %	-41.7 %	-23.73 %
MCAGU's Total Ranking	# 3689	# 4405	# 3911	# 3654	# 3487
Total Assets (TTM) in million	5	1	1	1	1
Seq. Total Assets Change	410.3 %	12.93 %	-31.33 %	0.18 %	4.78 %
Seq. Net Income Change	-	-	-	-	-

MCAGU's 5 Years Annual ROA >> Back to MCAGU Management Effectiveness >> Compare MCAGU ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 121
Sector	# 385
Overall	# 3512

Return On Assets Statistics
High	Average	Low
0.19 %	-17.81 %	-40.4 %
(Mar 31 2023)		(Sep 30 2025)

Financial Statements
Mountain Crest Acquisition V's Assets	$ 5 million	MCAGU's Balance sheet
Mountain Crest Acquisition V's Income	$ 0 million	Quarterly MCAGU's Income Statement
MCAGU's Income by Division		See MCAGU's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-24.48 %	-76.94 %	1752.06 %	-99.61 %	-
Total Assets in million	1	1	5	0	70
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	-2	0	0
Annual Return On Assets	-49.35 %	-32.37 %	-44.88 %	1.65 %	-0.22 %

MCAGU's 5 Years Annual ROA >> Back to MCAGU Management Effectiveness >> Compare MCAGU ROA to its Competitors

More Return On Assets Ratios
MCAGU's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MCAGU's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MCAGU's Competitors
Subscribers only: Roa for Mountain Crest Acquisition V's Suppliers
Subscribers only: Return On Assets for MCAGU's Customers

You may also want to know
MCAGU's Roi	MCAGU's Inventory Turnover Ratio	MCAGU's Growth Rates	MCAGU's Dividend Comparisons
	MCAGU's Profitability Ratios	MCAGU's Asset Turnover Ratio	MCAGU's Dividend Growth
MCAGU's Roe	MCAGU's Valuation Ratios	MCAGU's Financial Strength Ratios	MCAGU's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-15T07:30:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.